The KN-4006B uses two Philips 311nm UVB lamps and features a compact grey LCD screen with a built-in timer and controls.
This clinically proven, drug-free device is designed for the treatment of various skin conditions, including psoriasis, vitiligo, eczema, and similar disorders, affecting both the body and scalp. It employs original Philips™ UV-B/311 nm lamps, which emit a specific wavelength closely mimicking the sun’s natural spectrum. This targeted spectral energy distribution, with a peak at 311 nm, reduces potential side effects such as redness and itching, and requires shorter exposure times for effective results.
The KN-4006B is versatile and suitable for treating any part of the body. Its lightweight, portable design is powered by an included AC adapter, and UV goggles are provided for eye protection.
Treatment sessions are brief—typically 1-2 minutes, 3-4 times a week per area. Simply position the device against the affected area for treatment. Many users experience positive results within a week, though individual outcomes may vary based on the condition’s severity. It’s advisable to consult your dermatologist for comprehensive treatment guidance before use.
The KN-4006B has successfully assisted thousands of patients worldwide with psoriasis and vitiligo. While designed for home use, it is also employed by numerous dermatologists, clinics, and hospitals globally. The device meets stringent EU safety standards and holds CE certification, ensuring compliance with international health and safety directives.
Achieve effective treatment with minimal discomfort using the KN-4006B UVB phototherapy lamp. Order your affordable and versatile UVB lamp today!
—
Feel free to adjust any part to better fit your needs!
Overview
Maximum Efficiency
|
Humanized design
|
Buit-in timer
|
Easy to operate
|
Details
Specifications
Security grade |
Class II
|
||
Size
|
180mm×190mm×400mm(L×W×H) |
||
Net Weight
|
1.8kg
|
||
Working Distance
|
3cm±0.5cm
|
||
Effective Radiation Area
|
104cm2±10% |
What others are saying
There are no contributions yet.